US Stock MarketDetailed Quotes
BIIB Biogen
Watchlist
300.200
-2.210-0.73% Close 06/02 16:00 ET
300.750+0.550+0.18%
Post 18:05 ET
303.170High297.680Low817.15KVolume
302.530Open302.410Pre Close245.43MTurnover0.57%Turnover Ratio13.98P/E (TTM)43.45BMarket Cap319.74052wk High14.38P/E (Static)144.74MShares188.53552wk Low3.15P/B43.33BFloat Cap480.180Historical High--Dividend TTM144.32MShs Float2.625Historical Low--Div YieldTTM1.82%Amplitude300.348Avg Price1Lot Size
Company Profile
Symbol
BIIB
Company Name
Biogen
Listing Date
09/17/1991
Founded
1978
CEO
Mr. Christopher A. Viehbacher
Market
NASDAQ
Employees
8725
Securities Type
Ordinary Shares
Fiscal Year Ends
12-31
Address
225 Binney Street
City
Cambridge
Province
Massachusetts
Country
United States of America
Zip Code
02142
Phone
1-617-679-2000
Website
http://www.biogen.comDescription
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Company Executives
No Data